UK News: First Human-Pig Chimera Kidney Trial Approved for Terminal Patients
The Medicines and Healthcare products Regulatory Agency has approved the United Kingdom’s first clinical trial of a xenotransplantation kidney — an organ grown in a genetically modified pig using human genetic material designed to reduce the immune rejection that has historically been the primary barrier to successful transplants of animal organs into human patients. The trial, limited to a small cohort of terminally ill patients with no remaining conventional treatment options, represents a significant milestone in a field that has been advancing rapidly in recent years following breakthroughs in gene editing technology.
The pigs used to grow the organs have been modified to remove specific pig genes responsible for triggering the most severe rejection responses and to insert human genes that help make the organ’s proteins more compatible with the human immune system. The modifications are designed to narrow the molecular gap between pig and human biology enough to allow the transplanted kidney to function for a meaningful period, though researchers acknowledge that long-term outcomes remain uncertain given the absence of clinical data.
The transplantation of animal organs into humans — xenotransplantation — has been a research aspiration for decades, driven by the severe shortage of human donor organs that leaves many patients dying while awaiting suitable matches. If xenotransplantation could be made safe and effective, it would potentially eliminate the organ shortage entirely, as pigs can be bred specifically for organ donation at any required scale.
The trial’s approval follows preliminary results from work in the United States, where xenotransplantation kidneys have been placed in brain-dead recipients and more recently in living patients with terminal illness under compassionate use arrangements. Those early results showed function of the transplanted organs for periods of days to weeks, providing the first clinical data on how the modified pig organs perform in a living human body.
